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Summary  
An anti-peptide antibody was raised in a rabbit against he carboxy terminal region of the human fibromodulin core 
protein. The antibody was purified from other components ofthe resulting antiserum by affinity chromatography using 
the immobilized peptide, and was used to study the structural heterogeneity of fibromodulin extracted from human 
articular cartilage of different ages by the use of immunoblotting following sodium dodecyl sulfate polyacrylamide g l 
electrophoresis analysis of the extracted macromolecules. In the fetus and neonate, fibromodulin was visualized as a 
diffuse component with a relative molecular weight of 70-110 kDa, whereas in the mature adult a more discrete 
component of smaller size was apparent with a relative molecular weight of 67 kDa. The size of the fibromodulin from 
mature adult cartilage could not be altered by pretreatment of the samples with keratanase II or endo-fl-galactosidase 
before analysis. In contrast, the size of the fibromodulin from younger cartilage could be decreased with both 
glycosidases, with the endo-fl-galactosidase yi lding a smaller product han the keratanase. The size of the product 
resulting from endo-fl-galactosidase tr atment of the fibromodulin from young cartilage was the same as that of the 
intact fibromodulin from mature adult cartilage. Thus, fibromodulin is present in human articular cartilage at all ages, 
but the extracted molecules only appear to exist in a proteoglycan form possessing keratan sulfate chains in the juvenile 
and young adult, and the size of these chains decreases with age. In the mature adult the fibromodulin does not possess 
either keratan sulfate or non-sulfated polylactosamine chains, though it appears to possess the same number of N-linked 
oligosaccharides a its counterparts from the younger tissue, but they are not modified further. The majority of the 
fibromodulin extracted from arthritic cartilage is of the same size as that found in the normal mature adult, although 
there is evidence for proteolytic processing. The degree of such processing is greater for the fibromodulin obtained from 
the cartilage of rheumatoid arthritic joints than osteoarthritic joints. 
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I n t roduct ion  
FIBROMODULIN belongs to the family of small 
leucine-r ich repeat pr0teoglycans, that  also in- 
cludes decorin, biglycan and lumican [!]. The core 
proteins of these proteogylcans are character ized 
by a series of centra l  leucine-r ich domains f lanked 
by terminal  disulf ide-bonded domains [2-4]. In the 
case of decor in and biglycan there are at tachment  
sites for chondroi t in  sulfate or dermatan sulfate in 
the extreme amino-terminal  region of the core 
proteins, but these sites are absent from fibromod- 
ul in and lumican. The core proteins of all four 
molecules possess at tachment  sites for N-l inked 
ol igosaccharides in their  central  regions, and in 
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the case of f ibromodulin and lumican these 
ol igosaccharides may be modified to keratan 
sulfate. 
F ibromodul in  was first purified from mature  
bovine art icu lar  cart i lage as a matrix protein of Mr 
59 kDa [5]. It  was shown to be present in a var iety 
of cart i lage types and other  connective t issues at a 
concentrat ion of 1-3 mg/g wet tissue. The name 
f ibromodulin is derived from the abil ity of the 
protein to interact  with the fibril lar types I and I I  
col lagens and influence both the rate of fibrilloge- 
nesis and the st ructure of the result ing fibrils [6]. 
In teract ion with the fibril lar col lagens also 
appears to be a common feature of other  family 
members [7]. Decor in and f ibromodulin have been 
shown to interact  at defined sites a long the 
col lagen molecules, but do not compete for the 
same sites [8]. It  is l ikely that  f ibromodul in 
interacts with the col lagen fibrils at the a or c 
bands, whereas decorin interacts at the d or e 
bands [9]. 
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The bovine fibromodulin cDNA sequence indi- 
cates that the primary translation product contains 
375 amino acids with the first 18 residues 
representing the signal peptide [2]. The central 
leucine-rich region possesses 10 repeats of about 23 
amino acids, within which reside four consensus 
sequences for the attachment of N-linked oligosac- 
charides. A fifth such attachment site lies within 
the carboxy-terminal disulfide-bonded domain, but 
unlike the more central sites it does not appear to 
be substituted [10]. At least in calf cartilage, it 
appears that all four of the central sites may also 
serve as acceptors for the attachment of keratan 
sulfate chains with an average length o f  22 
disaccharide repeating units. 
In the human the structure of the primary 
translation product for fibromodulin has also been 
described [11]. It contains 376 amino acids, also 
with a putative 18 residue signal peptide, and has 
consensus sequences for N-linked oligosaccharides 
at identical positions to its bovine counterpart, 
though at present it is not known whether these 
sites are also substituted with keratan sulfate. The 
purpose of the present work was to determine 
whether keratan sulfate is indeed present on the 
fibromodulin of human articular cartilage and 
whether its substitution varies with age. 
Mater ia l s  and  Methods  
PREPARATION OF TISSUE EXTRACTS 
Normal human articular cartilage was obtained 
from the femoral condyles at the time of autopsy. 
Specimens were collected within 20 h of death from 
two fetuses (26 and 32 weeks gestation), two 
neonates (1 and 6 weeks after birth), three juveniles 
(2, 3 and 12 years), and eight adults (23, 37, 39, 55, 
60, 64, 68 and 74 years). In the case of the 60 and 
74 year adults, tissue was also collected from 
patellar tendon, meniscus, intervertebral disc 
(L4-5) and skin. In all cases the joints from which 
the tissue was taken appeared macroscopically 
normal and there was no clinical history of a 
connective tissue abnormality. Cartilage was also 
collected from the femoral condyles of 12 patients 
ungoing joint replacement surgery. Nine of these 
individuals (aged 52, 61, 62, 68, 70, 71, 72, 74 and 78 
years) had osteoarthritis and three (aged 64, 73 and 
74 years) had rheumatoid arthritis. Tissue was 
stored at -20°C until  used for extraction. For the 
preparation of extracts, cartilage was routinely 
finely diced then extracted with 10 volumes of 4 M 
guanidinium chloride, 100mM sodium acetate, 
pH 6.0, containing proteinase inhibitors for 48 h at 
4°C (12). In the cases where multiple tissues were 
collected, dicing was replaced by sectioning to 
20 pm. The filtered extracts were dialyzed into the 
appropriate buffer for enzyme treatment, hen used 
directly for sodium dodecyl sulfate polyacylamide 
gel electrophoresis (SDS-PAGE) and subsequent 
immunoblotting analysis without further purifi- 
cation. 
PREPARATION OF ANTI-PEPTIDE ANTISERUM 
A peptide (H-CGGLRLASLIEI-OH) correspond- 
ing to the carboxy terminal nine amino acids of 
human fibromodulin [11], plus a linker region 
consisting of two glycine residues and an amino 
terminal cysteine (Fig. 1), was synthesized by 
Fmoc chemistry (Fastmoc) using an Applied 
Biosystems model 431A solid phase peptide 
synthesizer. The cysteine residue was used for 
coupling the peptide to ovalbumin [13], using the 
bifunctional reagent N-hydroxysuccinimidyl bro- 
moacetate [14]. For production of the anti-peptide 
antibody, New Zealand White rabbits (3 kg) were 
injected intramuscularly with 0.5 ml of a suspen- 
sion comprising a 1:1 mixture of Freund's 
complete adjuvant and the conjugated peptide 
in phosphate-buffered saline (PBS, 2 mg/ml). 
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FIG. 1. Relationship of the peptide sequence used for antibody production to the intact fibromodulin molecule. (a) The 
core protein of fibromodulin is depicted as a series of central eueine-rieh regions with flanking disulfide-bonded 
domains near the amino (N) and carboxy (C) termini. (b) The amino acid sequence of the carboxy terminal region 
commencing with the cysteine residue involved in disulfide-bond formation. (e) The sequence of the peptide synthesized 
to correspond to the carboxy terminal region of fibromodulin, which also possesses an amino terminal cysteine residue 
and adjacent spacer glycine residues (underlined). (d) The terminal eysteine residue is used for coupling the peptide 
to ovalbumin for immunization. 
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Subsequent booster injections were given after 2, 4, 
6 and 8 weeks, bt/t using incomplete adjuvant. The 
animals were killed and bled out 2 weeks after the 
final boost. 
PURIFICATION OF ANTI-FIBROMODULIN 
IMMUNOGLOBULIN 
The specific antibodies in the anti-peptide 
antiserum were purified by passage through a 
column of the immobilized immunizing peptide. 
The peptide was immobilized by coupling to 
Sulfolink gel (Pierce) via its amino terminal 
cysteine residue, asdescr ibed by the manufacturer. 
Following coupling, unreacted sites on the gel were 
blocked using cystiene. For antibody purification, a
column containing 5 ml peptide-resin was equili- 
brated with PBS. Twenty-five millilitres of anti- 
serum was then passed through the column at a 
flow rate of 2ml/h at room temperature. The 
column was washed, first with PBS and then with 
1 M NaC1 to eliminate nonspecific interactions. 
Finally, salt was removed by washing with PBS, 
and the antibodies eluted using 0.1 M glyeine, 
pH 2.8. Four milliliter fractions were collected and 
immediately neutralized by the addition of 200 ~l 
1.0 M Tris/HC1, pH 9.5. Fractions were monitored 
for protein content by absorbance ~t 280 urn, and 
the positive fractions were pooled and dialyzed 
against PBS. The final solution had a volume of 
9 ml and an absorbance at 280 nm (A280) of 0.45, 
equivalent o 0.32 mg/ml of immunoglobulin. 
SDS-PAGE AND IMMUNOBLOTTING 
Cartilage extracts were dialyzed overnight 
against 0.1M sodium acetate, 0.1M Tris/HC1, 
pH 7.3, then treated with chondroitinase ABC 
(from Proteus vulgaris, supplied by ICN Biomedi- 
cals) at 0.1 U/ml extract for 4 h at 37°C. The treated 
extracts were mixed 1:1 with SDS-PAGE loading 
buffer, heated for 3 min at 100°C, and analyzed in a 
10% polyacrylamide slab gel under reducing 
conditions [15]. After electrophoresis, fractionated 
proteins were electrophoretically transferred to 
nitrocellulose membranes [16], and fibromodulin 
components were detected by immunoblotting 
analysis, as described previously for the detection 
of decorin and biglycan [17]. Briefly, after blocking 
with bovine serum albumin the membrane was 
exposed to a 1:2500 dilution of the affinity-purified 
anti-fibromodulin antibody, followed by washing 
and subsequent exposure to an alkaline phospha- 
tase-conjugated goat anti-rabbit immunoglobulin 
(Promega). Fibromodulin components were ulti- 
mately visualized by reaction with NitroBlue 
Tetrazolium and 5-bromo-4-chloro-3-indolyl phos- 
phate. In some experiments the anti-fibromodulin 
antibody was preincubated for 24h with the 
synthetic peptide (1.5 mg/ml) used for its gener- 
ation, so that detection specificity could be 
ascertained. Estimates of the molecular size of 
immunoreactive fibromodulin were made by com- 
parison with the electrophoretic migration of 
standard proteins of known size. 
KERATANASE AND ENDO-fi-GALACTOSIDASE 
TREATMENT 
In order to study glycosylation of the fibromod- 
ulin core protein, tissue extracts following chon- 
droitinase treatment were dialyzed into 0.01 M 
sodium acetate, pH 6.0, for digestion with ker- 
atanase II (from Bacillus sp., supplied by PDI 
Bioscience) or endo-fl-galactosidase (from Es- 
cherichia freundii, supplied by ICN Biomedicals). 
The enzymes were both used at a concentration of 
0.1 U/ml of extract and digestions were carried out 
for 20 h at 37°C. Following digestion, samples were 
mixed 1:1 with SDS-PAGE loading buffer, heated 
for 3 min at 100°C, and analyzed by SDS-PAGE and 
immunoblotting. 
Resu l ts  
The presence of fibromodulin was studied in 
extracts of human articular cartilage, using a 
combination of SDS-PAGE, electroblotting and 
immuno-detection with an anti-peptide antibody. 
The extracts were studied directly without any 
prior fractionation so that all possible forms of the 
molecule could be detected without any bias 
because of the form of glycosylation. The analysis 
of direct extracts did, however, necessitate the 
treatment of the samples with chondroitinase ABC 
before electrophoresis because optimal resolution 
was not obtained in the presence of large quantities 
of aggrecan. Using this procedure, the cartilage 
extracts from a 6-week-old neonate showed a broad 
band of immunoreactive material, with a size 
ranging between 70-110 kDa (Fig. 2). The specifi- 
city of the immune reaction was demonstrated by 
using an antibody preparation that had been 
pretreated with the immunizing peptide. This 
competition completely abolished the immune 
staining. 
To determine whether the size of the fibromod- 
ulin changes with age, extracts from a variety of 
individuals were examined. A juvenile of 3 years 
showed a broad size distribution similar to the 
neonate (Fig. 3), although the average size was 
slightly smaller with a range of 65-100 kDa. In 
156 Roughley et  a l . :  Human cartilage fibromodulin 
112 000 
84 000 
~- -  53 200 
34 900 
~- -  28 700 
geneity of the f ibromodul in f rom the mature adult  
cart i lage (Fig. 4). In contrast,  both glycosidases 
caused a decrease in size of the juveni le and young 
adult  samples (Figs 5 and 6), with the size 
diminut ion being greatest  for the endo-fl-galactosi- 
dase (Fig. 6). This enzyme decreased the average 
size of the f ibromodul in from these tissues to about 
67 kDa, to yield a size distr ibut ion equivalent o 
that  observed for the intact  molecules from the 
mature adult  carti lage. The lack of act ion of e i ther  
glycosidase on the f ibromodul in from the mature 
adult  cart i lage would indicate that  the predomi- 
nant  form was subst i tuted with nei ther  keratan 
sulfate nor  poly lactosami~e chains, whereas the 
f ibromodul in from the juveni le and young adult  
does appear to possess uch glycosylation. Because 
the size of the f ibromodul in core protein is the 
same for all ages after t reatment  with endo-fl- 
galactosidase, it is l ikely that  the same number  of 
asparagine residues are involved in N-l inked 
4~-  20 500 
Peptide - + 
FIG. 2. Specificity of anti-peptide antibody. A cartilage 
extract from a 6-week-old neonate was analyzed by 
SDS-PAGE and subsequent immunoblotting. The anti- 
peptide antibody against fibromodulin was used either 
directly (-) or following pretreatment with the immuniz- 
ing peptide (+). The migration positions of molecular 
weight standards are also indicated. 
contrast,  two adults of 37 and 64 years showed 
narrower size distr ibut ion ranges, with predomi- 
nent  components of about 67 kDa. This was by far 
the major component  in the mature  adult, but 
molecules of larger size were evident in the young 
adult. Thus, the size of the human cart i lage 
f ibromodul in decreases with age, to reach a 
minimum size in the mature adult. The size change 
takes place cont inuously  from the juveni le to the 
young adult  (data not shown). 
To determine the contr ibut ion of keratan sulfate 
to the observed size heterogeneity,  the samples 
were t reated with either keratanase II or endo-fi- 
galactosidase before e lectrophoret ic  analysis. The 
former enzyme will cleave all forms of keratan 
sulfate, including those that  have sulfate groups on 
both the galactose and N-acetylglucosamine moi- 
eties. The latter  enzyme will cleave at non-sulfated 
disaccharides within the keratan sulfate chain or 
within unmodif ied poly lactosamine chains. Ne i ther  
the keratanase II nor the endo-fl-galactosidase 
caused any signif icant change in the size hetero- 
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FIG. 3. Analysis of fibromodulin from cartilage of 
different ages. Cartilage xtracts from individuals aged 6 
weeks (1), 3 years (2), 37 years (3) and 64 years (4) were 
analyzed by SDS-PAGE and subsequent immunoblotting 
using the anti-peptide antibody against fibromodulin. 
The migration positions of molecular weight standards 
are also indicated. 
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FIG. 4. Analysis of fibromodulin from mature cartilage 
after treatment with keratanase II or endo-fl-galactosi- 
dase. Cartilage extracts from an individual aged 64 years 
were analyzed by SDS-PAGE, following their treatment 
with endo-fl-galactosidase (1), no enzyme (2) or ker- 
atanase II (3). The migration positions of molecular 
weight standards are also indicated. 
glycosylat ion at all ages. The age-related i f ference 
in the size of the in tact  f ibromodul in is then a 
resul t  of the extent to which po ly lactosamine 
e longat ion and sul fat ion may be occurr ing.  
The e lectrophoret ic  profi le of f ibromodul in  in the 
normal  mature  adult  was compared  wi th  that  from 
individuals wi th  ar thr i t i c  jo ints (Fig. 7). In pat ients  
with osteoarthr i t is ,  the major  form of f ibromodul in 
was of ident ica l  Size to that  present  in the normal  
cart i lage, a l though in some individuals there was 
evidence for proteolys is  occurr ing  to a minor  
extent,  as products  of a smal ler  s i zewere  apparent .  
In pat ients  wi th  rheumato id  arthr i t is ,  the largest  
product  was also the same size as that  present  in 
the normal  adult,  but  proteolys is  occur red  to a 
much greater  extent  than  in the pat ients  with 
osteoarthr i t is .  In  ne i ther  form of ar thr i t i s  did the 
f ibromodul in show evidence of s igni f icant substi- 
tut ion by long po ly lactosamine chains or keratan  
sulfate. 
The size heterogenei ty  of f ibromodul in was also 
studied in a var iety  of dif ferent mature  adult  
connect ive t issues (Fig. 8). The meniscus and the 
annu lus  f ibrosus of the in terver tebra l  disc showed 
the presence of f ibromodul in  hav ing a s imi lar  size 
heterogene i ty  to that  present  in the ar t i cu la r  
cart i lage. F ib romodu l in  was also detected in 
the pate l lar  tendon,  but  its size was smal le r  than  
that  in the other  t issues. Two components  of 
s imi lar  abundance  were observed wi th  molecu lar  
sizes of about  60 and 55 kDa. L i t t le  immunoreact ive  
f ibromodul in  was detected in e i ther  sk in or 
the nucleus pu lposus  of the in terver tebra l  disc. 
Thus, it would appear  that  f ibromodul in  is not  
present  at a h igh level in al l  adult  connect ive 
tissues, and that  in those t issues where  it is 
present  it does not  exhibi t  he size heterogene i ty  
expected for a keratan  su l fate-subst i tuted mol- 
ecule. Fur ther  work is needed, however, to 
determine in which t issues f ibromodul in  may be 
present  in younger  individuals and what  its 
mo lecu lar  state may be. 
Discuss ion  
The data presented in this work suggest that  in 
the  juvenile, human ar t i cu la r  cart i lage possesses 
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FIG. 5. Analysis of fibromodulin from cartilage of 
different ages after treatment with keratanase II. 
Cartilage extracts from individuals aged 6 weeks (1), 3 
years (2), 37 years (3) and 64 years (4) were analyzed by 
SDS-PAGE, following their treatment with keratanase II,
and subsequent immunoblotting using the anti-peptide 
antibody against fibromodulin. The migration positions 
of molecular weight standards are also indicated. 
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FIG. 6. Analysis of fibromodulin from cartilage of 
different ages after treatment with endo~fi-galactosidase. 
Cartilage extracts from individuals aged 6 weeks (t), 3 
years (2), 37 years (3) and 64 years (4) were analyzed by 
SDS-PAGE, following their treatment with endo-fl-galac- 
tosidase, and subsequent immunoblotting using the 
anti-peptide antibody against fibromodulin. The mi- 
gration positions of molecular weight standards are also 
indicated. 
In the mature adult,  f ibromodul in from human 
art icu lar  cart i lage does not appear  to be subst i -  
tuted with keratan sulfate or poly lactosamine 
chains to any great degree because glycosidases 
expected to cleave such carbohydrate modif icat ion 
had no effect. The size of the adult  f ibromodul in is, 
however, larger than one would expect for a 
non-glycosylated core protein.  Based on the 
deduced amino acid sequence, the mature human 
fibromodUlin core prote in wi thout  post-transla- 
t ional  modif ication should have a molecular  size of 
about 42 kDa. Thus the size of 67 kDa observed for 
f ibromodul in in the adult  is l ikely due, at least in 
part,  to glycosylation by N-l inked ol igosaccharides. 
Pre l iminary  studies with N-glycanase F, which 
cleaves the asparagine --* N-acetylg lucosamine 
l inkage that  attaches all N-l inked ol igosaccharides 
to protein,  would support  the presence of such 
subst itut ion.  Fur thermore ,  it appears l ikely that  
the degree to which such subst i tut ion is occurr ing 
is the same at all ages. 
This scenario, of f ibromodul in existing as a 
glycoprotein form in the adult  and a proteoglycan 
f ibromodulin that  is subst i tuted with polylac- 
tosamine chains that,  at least in part,  are sulfated 
to form keratan sulfate. The inabi l i ty of keratanase 
II to remove these chains to the same degree as 
endo-/~-galactosidase would indicate that  many 
of the poly lactosamine chains are non-sul~hted, 
part icular ly  in the region proximal to their  
at tachment  to the core protein.  Such a distr ibut ion 
of sulfation has previously been described for 
corneal  keratan sulfate [18]. Thus in the juvenile, 
f ibromodulin exists as a typical  keratan sulfate 
proteoglycan with the keratan sulfate account ing 
for about 50% of the mass of the molecule. If  one 
assumes that  the same four subst i tut ion sites are 
uti l ized as occurs in bovine f ibromodul in [10], then 
the average size of the keratan sulfate chains would 
be about 10 kDa assuming a uni form substitut ion. 
The size of the chains could be considerably 
longer, however, if subst i tut ion occurred only at a 
l imited number  of sites. The size of these chains 
decreases with juveni le development and in the 
young adult. 
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FIG. 7. Analysis of fibromodulin from arthritic cartilage. 
Cartilage extracts from individuals with osteoarthritis 
(2 and 3) and rheumatoid arthritis (4 and 5) were 
analyzed by SDS-PAGE and subsequent immunoblotting 
using the anti-peptide antibody against fibromodulin. 
The appearance ofextracts from normal mature adult (1) 
and fetal (6) cartilage are also shown for comparison. 
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FIG. 8. Analysis of fibromodulin from different adult connective tissues. Extracts from the meniscus (1), patellar tendon 
(2), annulus fibrosus (3), nucleus pulposus (4), articular cartilage (5) and skin (6) of an individual aged 60 years were 
analyzed by SDS-PAGE and subsequent immunoblotting using the anti-peptide antibody against fibromodulin. The 
migration positions of molecular weight standards are also indicated. 
form in the juvenile, is compatible with previous 
studies on bovine cartilage, where fibromodulin 
was isolated as a 59 kDa matrix protein from 
2-year-old animals [5], but as a larger keratan 
sulfate proteoglycan from 3~week-old calves [10]. It 
is not, however, certain that this age-change occurs 
in cartilage from all species, as fibromodulin 
substituted with keratan sulfate is produced by 
chondrocytes from both young and adult rabbit 
cartilage [19]. 
The occurrence of a predominantly glycoprotein 
form for fibromodulin in mature normal cartilage 
also appears to be true for both osteoarthrit ic and 
rheumatoid arthrit ic cartilage. Although the 
expression of immature proteoglycan glycosylation 
patterns has been reported to occur for aggrecan in 
osteoarthrit is [20], there is no evidence that any 
repair process taking place within the cartilage of 
the arthrit ic joints results in the accumulation of 
proteoglycan forms of the fibromodulin character- 
istic of the young. However, the fibromodulin that 
was present in the arthrit ic joints did show 
evidence for increased proteolytic processing, as 
has been reported previously for decorin and 
biglycan [20]. Thus the increased proteolytic action 
associated with the arthrit ic joint appears to affect 
the structure of all the proteoglycans present in the 
cartilage. 
The presence of a glycoprotein form of fibromod- 
ulin in the mature adult does not appear to be 
unique to art icular cartilage, and molecules of 
identical size are also present in the meniscus and 
annulus fibrosus of the intervertebral disc. In the 
patellar tendon, an even smaller sized fibromodulin 
is p~esent, suggesting that in some tissues a low 
degree of glycosylation or proteolytic processing 
may be occurring. In contrast to the annulus 
fibrosus, the nucleus pulposus of the intervertebral  
disc showed no evidence for the presence of 
fibromodulin in either a proteoglycan or a 
glycoprotein form. A similar situation was pre- 
viously reported in the bovine intervertebral disc 
[5], where immunoassay revealed a 20-fold differ- 
ence in the fibromodulin content of the annulus 
fibrosus and nucleus pulposus from a 2-year-old 
animal. In the present work a sample of adult 
160 Roughley et al.: Human cartilage fibromodulin 
dermis failed also to show the presence of 
fibromodulin. At present it is not clear why 
different connective tissues would require different 
abundances of a collagen-binding proteoglycan, or 
whether other members of the leucine-rich repeat 
proteoglycan family may increase in a compensa- 
tory manner. 
Finally, it is of interest o consider the possible 
mechanism by which cartilage fibromodulin may be 
converted from a proteoglycan to a glycoprotein 
form. In theory this could involve the degradative 
removal of keratan sulfate following its initial 
synthesis, or a synthetic failure to extend the 
N-linked oligosaccharides to sulfated polylac- 
tosamine chains. The degradative pathway is 
unlikely by either proteinase or glycosidase action. 
Proteolytic onversion of biglycan from a proteo- 
glycan to a glycoprotein form likely occurs in adult 
human cartilage and intervertebral disc [17]. 
However, for a similar mechanism to occur in 
fibromodulin, proteolysis would be required within 
the central region of the core protein where 
glycosylation occurs. This would result in a 
considerable decrease in the core protein size, yet 
no such change was observed in the normal adult. 
The action of a keratan sulfate-degrading glycosi- 
dase would be expected to affect he keratan sulfate 
of both fibromodulin and aggrecan, yet it has been 
reported that the keratan sulfate chains of 
aggrecan increase in size with age [21]. One would, 
therefore, seem justified in speculating that the 
absence of keratan sulfate on fibromodulin is 
a result of a lack of its synthesis by the mature 
adult chondrocytes. Because the adult chondro- 
cytes are known to possess the transferases 
necessary for synthesizing O-linked keratan sulfate 
on aggrecan, one presumes that the fibromodulin 
does not proceed through the same intracellular 
compartment, or that the sites for polylactosamine 
chain extension on the initial N-linked oligosac- 
charides are selectively blocked. In this respect, it 
is interesting to note that lumican, the other 
keratan sulfate proteoglycan in the leucine-rich 
proteoglycan family, shows a similar age-related 
change in keratan sulfate substitution to fibro- 
modulin [22]. 
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